Search research articles
Contact Us
Filters
Showing results (1-10 of 8) with videos related to
Page
of 1
Sort By:
Epigenetics Insights
|
April 11, 2019
Epigenetic Classifiers for Precision Diagnosis of Brain Tumors
Javier Ij Orozco, Ayla O Manughian-Peter, Matthew P Salomon, et al.
Molecular Immunology
|
November 19, 2019
Recombinant C1q variants modulate macrophage responses but do not activate the classical complement pathway
Victoria Espericueta, Ayla O Manughian-Peter, Isabelle Bally, et al.
Clinical & Experimental Metastasis
|
May 31, 2018
Alternative splicing and cancer metastasis: prognostic and therapeutic applications
Diego M Marzese, Ayla O Manughian-Peter, Javier I J Orozco, et al.
Annals of Surgical Oncology
|
July 26, 2019
Clinicopathological Features of Triple-Negative Breast Cancer Epigenetic Subtypes
Maggie L DiNome, Javier I J Orozco, Chikako Matsuba, et al.
Annals of Surgical Oncology
|
July 26, 2019
Clinical Implications of Transcriptomic Changes After Neoadjuvant Chemotherapy in Patients with Triple-Negative Breast Cancer
Javier I J Orozco, Janie G Grumley, Chikako Matsuba, et al.
Scientific Data
|
November 7, 2018
Brain metastasis DNA methylomes, a novel resource for the identification of biological and clinical features
Matthew P Salomon, Javier I J Orozco, James S Wilmott, et al.
Nature Communications
|
December 11, 2025
C1q drives neural stem cell quiescence by regulating cell cycle and metabolism through BAI1
Katja M Piltti, Anita Lakatos, Francisca Benavente-Perez, et al.
Nature Communications
|
November 8, 2018
Epigenetic profiling for the molecular classification of metastatic brain tumors
Javier I J Orozco, Theo A Knijnenburg, Ayla O Manughian-Peter, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 8) with videos related to
Sort By:
Page
of 1
Epigenetics Insights
|
April 11, 2019
Epigenetic Classifiers for Precision Diagnosis of Brain Tumors
Javier Ij Orozco, Ayla O Manughian-Peter, Matthew P Salomon, et al.
Molecular Immunology
|
November 19, 2019
Recombinant C1q variants modulate macrophage responses but do not activate the classical complement pathway
Victoria Espericueta, Ayla O Manughian-Peter, Isabelle Bally, et al.
Clinical & Experimental Metastasis
|
May 31, 2018
Alternative splicing and cancer metastasis: prognostic and therapeutic applications
Diego M Marzese, Ayla O Manughian-Peter, Javier I J Orozco, et al.
Annals of Surgical Oncology
|
July 26, 2019
Clinicopathological Features of Triple-Negative Breast Cancer Epigenetic Subtypes
Maggie L DiNome, Javier I J Orozco, Chikako Matsuba, et al.
Annals of Surgical Oncology
|
July 26, 2019
Clinical Implications of Transcriptomic Changes After Neoadjuvant Chemotherapy in Patients with Triple-Negative Breast Cancer
Javier I J Orozco, Janie G Grumley, Chikako Matsuba, et al.
Scientific Data
|
November 7, 2018
Brain metastasis DNA methylomes, a novel resource for the identification of biological and clinical features
Matthew P Salomon, Javier I J Orozco, James S Wilmott, et al.
Nature Communications
|
December 11, 2025
C1q drives neural stem cell quiescence by regulating cell cycle and metabolism through BAI1
Katja M Piltti, Anita Lakatos, Francisca Benavente-Perez, et al.
Nature Communications
|
November 8, 2018
Epigenetic profiling for the molecular classification of metastatic brain tumors
Javier I J Orozco, Theo A Knijnenburg, Ayla O Manughian-Peter, et al.
Page
of 1